2Webb AR,Mythen MG,Jacobson D,et al. Maintaining blood flow in the extracorporeal circuit:haemostasis and anticoagulation[J].lntensive Care Med, 1995,21 ( 1 ) : 84-93. 被引量：1
3Baldwin I. Factors affecting circuit patency and filter 'life'[J].Contrib Nephrol, 2007,156 : 178-184. 被引量：1
4Kleger GR, Fassler E. Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill? [J].Int J Artif Organs,2010,33(3) : 139-146. 被引量：1
6Zhang Z,Hongying N.Efficacy and safety of regional citrate anticoa- gulation in critically ill patients undergoing continuous renal repla- cement therapy[J].Intensive Care Med,2012,38(1):20-28. 被引量：1
7Uchino S,Fealy N,Baldwin I,et al.Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration:impact on filter life and azotemic control[J].Nephron Clin Pract,2003,94(4) :C94-98. 被引量：1
8Hotbauer R,Moscr D,Frass M,et al.Role of contact system activation in hemodialyzer-induced thrombogenicity[J]. Kidney Int,2001,60:1972-1981. 被引量：1
9Polanska K,Opatrny K, Rokyta R, et al.Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF [J].Ren Fail,2006,28(2) : 107-118. 被引量：1
10Morena M ,Jaussent I, Chalabi L, et al.Biocompatibility of heparin- grafted hemodialysis membranes:impact on monocyte chemoattractantprotein-! circulating level and oxidative status[J].Hemodial Int,2010, 14(4) :403-410. 被引量：1
